Kinarus further strengthens its leadership with two reputed industry experts

Kinarus further strengthens its leadership with two reputed industry experts
EQS Group-News: Kinarus AG
/ Key word(s): Personnel/Private Equity
26.04.2021 / 07:01
Hari Kumar, former CEO of Adheron Therapeutics, Inc. appointed Chairman of the Board of Directors
Thierry Fumeaux, MD, former member of Swiss National Covid Taskforce, joined Kinarus as new Chief Medical Officer
Basel, Switzerland, April 26, 2021. Kinarus AG, a Swiss clinical-stage biopharmaceutical company and owner of KIN001, a differentiated therapeutic candidate for the treatment of multiple diseases with high unmet need, announced today the appointment of Hari Kumar as Chairman of the Board of Directors and Thierry Fumeaux as Chief Medical Officer.

Related Keywords

Switzerland ,Swiss ,Thierry Fumeaux ,Alexander Bausch ,Hari Kumar ,Bristol Myers Squibb ,Adheron Therapeutics Inc ,Swiss National Covid Taskforce ,Amira Pharmaceuticals Inc ,Roche To Eisai Ltd ,Private Equity ,Adheron Therapeutics ,Chief Medical ,Eisai Ltd ,European Marketing ,Global Head ,Amira Pharmaceuticals ,Chief Business Officer ,Chief Executive Officer ,Idiopathic Pulmonary Fibrosis ,Finanznachrichten ,Dhoc ,Aktien ,Ktienkurse ,örse ,Apitalmarktinformationen ,Itteilungen ,Achrichten ,News ,Irtschaft ,சுவிட்சர்லாந்து ,சுவிஸ் ,அலெக்சாண்டர் பாஷ் ,ஹரி குமார் ,பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் ,ப்ரைவேட் பங்கு ,தலைமை மருத்துவ ,ேசை லிமிடெட் ,ஐரோப்பிய சந்தைப்படுத்தல் ,உலகளாவிய தலை ,அமிரா மருந்துகள் ,தலைமை வணிக அதிகாரி ,தலைமை நிர்வாகி அதிகாரி ,எவ்ஸ் ,